Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Spasovski, G. (Goce)
221  Ergebnisse:
Personensuche X
?
1

The blood flow rate on the first day after arteriovenous fi..:

Gjorgjievski, Nikola ; Dzekova‐Vidimliski, Pavlina ; Cibrev, Dragan...
Therapeutic Apheresis and Dialysis.  27 (2022)  3 - p. 530-539 , 2022
Link: https://doi.org/10.1111/..
 
?
2

Neuropeptide Y as a risk factor for cardiorenal disease and..:

Zoccali, Carmine ; Ortiz, Alberto ; Blumbyte, Inga Arune...
Nephrology Dialysis Transplantation.  37 (2021)  Supplement_2 - p. ii14-ii23 , 2021
Link: https://doi.org/10.1093/..
 
?
3

Mild cognitive impairment and kidney disease: clinical aspe..:

Viggiano, D. (Davide) ; Wagner, C.A. (Carsten) ; Blankestijn, P.J. (Peter)...
http://repub.eur.nl/pub/123968.  , 2020
Link: http://repub.eur.nl/pub/..
 
?
4

Guía de práctica clínica sobre el diagnóstico y tratamiento..:

Spasovski, G. (Goce) ; Vanholder, R. (Raymond) ; Allolio, B. (Bruno)...
http://repub.eur.nl/pub/101191.  , 2017
Link: http://repub.eur.nl/pub/..
 
?
5

Bone histomorphometry before and after long-term treatment ..:

Behets, Geert J. ; Spasovski, Goce ; Sterling, Lulu R....
Kidney International.  87 (2015)  4 - p. 846-856 , 2015
Link: https://doi.org/10.1038/..
 
?
6

PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Ure..:

Vanholder, Raymond ; Abou‐Deif, Omar ; Argiles, Angel...
Seminars in Dialysis.  22 (2009)  4 - p. 323-328 , 2009
Link: https://doi.org/10.1111/..
 
?
7

Neuropeptide Y as a risk factor for cardiorenal disease and..:

Bruchfeld, Annette ; Spoto, Belinda ; Sarkeviciene, Vaiva...
b0d8d0ad-1876-43dc-9807-8c47785ff0c4.  , 2022
Link: https://doi.org/10.1093/..
 
?
8

Neuropeptide Y as a risk factor for cardiorenal disease and..:

Zoccali, Carmine ; Ortiz, Alberto ; Blumbyte, Inga Arune...
Nephrology, Dialysis and Transplantation, 0931-0509, 2022, 37, s. 14-23.  , 2022
Link: http://urn.kb.se/resolve..
 
?
9

Neuropeptide Y as a risk factor for cardiorenal disease and..:

Zoccali, Carmine ; Ortiz, Alberto ; Blumbyte, Inga Arune...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713155/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Neuropeptide Y as a risk factor for cardiorenal disease and..:

Zoccali, Carmine ; Ortiz, Alberto ; Blumbyte, Inga Arune...
https://boris.unibe.ch/161522/.  , 2021
Link: https://boris.unibe.ch/1..
 
?
11

Diagnosis and Prediction of CKD Progression by Assessment o..:

Schanstra, Joost P ; Zürbig, Petra ; Alkhalaf, Alaa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520165/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
12

Bone histomorphometry before and after long-term treatment ..:

Behets, Geert J ; Spasovski, Goce ; Sterling, Lulu R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
13

Clinical practice guideline on diagnosis and treatment of h..:

Spasovski, Goce ; Vanholder, Raymond ; Allolio, Bruno...
uri/info:doi/10.2478/bj-2014-0014.  , 2014
Link: http://hdl.handle.net/20..
 
?
14

Bilateral renal angiomyolipomas and subependymal giant cell..:

Rambabova Bushljetik, I ; Lazareska, M ; Barbov, I...
Balkan Journal of Medical Genetics.  23 (2021)  2 - p. 93-98 , 2021
Link: https://doi.org/10.2478/..
 
?
15

Nephrin and podocalyxin - podocyte markers for early detect..:

Kostovska, I. ; Tosheska trajkovska, K. ; Labudovic, D....
Atherosclerosis.  275 (2018)  - p. e193 , 2018
Link: https://doi.org/10.1016/..
 
1-15